• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Midsona: Another quarter of margin over momentum - ABG

MSON BEksterne analyser17.07.2026, 08.50

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier

Download analyse (PDF)
* Adj. EBIT SEK 20m, 7% below ABGSCe SEK 21m
* Continued sales drag from contract manufacturing
* Consensus adj. EBIT revisions likely down low-single-digits

Growth recovery a story for H2, not Q2

The Q2 report was softer than expected on both sales and adj. EBIT. Net sales came in at SEK 870m, 2% below ABGSCe SEK 885m and only 0.6% above last year's SEK 865m. Organic growth was -1.2%, missing ABGSCe's +0.9% by a chunky 2.1pp and only marginally better than the -2.0% comp from Q2'25. Gross margin was the bright spot, in line with ABGSCe at 28.7% reported and 29.3% adjusted, driven by a richer own-brand mix and tight production cost control. However, that didn't carry through to adj. EBIT, which landed at SEK 20m which missed ABGSCe SEK 21m by 7%, with the adj. EBIT margin of 2.3% 0.1pp light of the 2.4% estimate. Opex was a bit elevated as management stepped up marketing behind priority brands. Segment-wise, Nordics was the standout, adj. EBIT of SEK 38m vs. SEK 25m a year ago on 0.5% organic growth. PTP and net profit both beat on lower net financial expenses and 0m in taxes.

Spain clarity and Risenta integration are the next checkpoints

On Risenta, it was consolidated on 1 June and contributed to growth by 1.3%.The Risenta production equipment handover is scheduled for autumn 2026, when the brand is meant to be folded into Midsona's own manufacturing base; until then, only the brand and finished-goods inventory sit on the balance sheet. Midsona has yet to reach an official decision on the long-term plan for operations in Spain, but noted that clarification will be provided during Q3. Marketing investment behind priority own brands is described as "gradually" delivering sales gains and is expected to continue at an elevated sequential level, meaning opex is unlikely to snap back down in H2. On costs, management notes raw material and packaging input prices have been relatively stable but sees no clear picture into year-end, flagging that recent fertiliser price rises could feed through to some raw material and finished-goods costs in H2. Transport and packaging cost pressure tied to the Middle East situation is called "manageable" so far but explicitly ongoing.

Likely no dramatic changes to consensus estimates

The share, which has been very strong YTD, is trading at ~10x NTM EV/EBITA on our unrevised estimates. Our initial understanding of the report as well as a mechanical calculation suggest that consensus' adj. EBIT estimates for '26e-'28e could be negative within a low-single-digit range, however, the lower tax and net financials could lift EPS estimates. The company will host a presentation of the Q2 report at CET 11.00 (link).